In vitro performance assessment of new beta Ti–Mo–Nb alloy compositions

New β-titanium based alloys with low Young's modulus are currently required for the next generation of metallic implant materials to ensure good mechanical compatibility with bone. Several of these are representatives of the ternary Ti–Mo–Nb system. The aim of this paper is to assess the in vit...

Full description

Saved in:
Bibliographic Details
Published in:Materials Science & Engineering C 2015-02, Vol.47, p.105-113
Main Authors: Neacsu, Patricia, Gordin, Doina-Margareta, Mitran, Valentina, Gloriant, Thierry, Costache, Marieta, Cimpean, Anisoara
Format: Article
Language:English
Subjects:
3T3 Cells
Alloys - chemistry
Animals
Beta titanium alloys
Biocompatibility
Biological
Biomaterials
Biomedical materials
Bones
Chemical Sciences
Differentiation
In Vitro Techniques
In vitro testing
Inflammatory response
Macrophage
Macrophages - cytology
Material chemistry
Mice
Molybdenum - chemistry
Niobium - chemistry
Pre-osteoblast
Surgical implants
Titanium
Titanium - chemistry
Ti–Mo–Nb
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:New β-titanium based alloys with low Young's modulus are currently required for the next generation of metallic implant materials to ensure good mechanical compatibility with bone. Several of these are representatives of the ternary Ti–Mo–Nb system. The aim of this paper is to assess the in vitro biological performance of five new low modulus alloy compositions, namely Ti12Mo, Ti4Mo32Nb, Ti6Mo24Nb, Ti8Mo16Nb and Ti10Mo8Nb. Commercially pure titanium (cpTi) was used as a reference material. Comparative studies of cell activity exhibited by MC3T3-E1 pre-osteoblasts over short- and long-term culture periods demonstrated that these newly-developed metallic substrates exhibited an increased biocompatibility in terms of osteoblast proliferation, collagen production and extracellular matrix mineralization. Furthermore, all analyzed biomaterials elicited an almost identical cell response. Considering that macrophages play a pivotal role in bone remodeling, the behavior of a monocyte-macrophage cell line, RAW 264.7, was also investigated showing a slightly lower inflammatory response to Ti–Mo–Nb biomaterials as compared with cpTi. Thus, the biological performances together with the superior mechanical properties recommend these alloys for bone implant applications. •Ti–Mo–Nb compositions show a fully β-microstructural state by XRD analysis.•Similar osteoblast growth and differentiation is displayed by β-Ti alloys and cpTi.•Ti–Mo–Nb alloys elicit a slightly lower inflammatory response than cpTi.
ISSN:0928-4931
1873-0191
DOI:10.1016/j.msec.2014.11.023